I would respectfully disagree with @Eric M. Horwitz and @Amar U. Kishan on this subject. Probably because the issue is much more complicated than they elude.One thing that is not complicated is that dose is dose. Or rather effective dose is effective dose. So any method of accurately deliv...

I would not use an SBRT boost for intermediate or high risk prostate cancer.  Although the radiobiology of an SBRT boost and brachytherapy boost are similar, there is minimal data looking at the efficacy and toxicity of combining IMRT and an SBRT boost.  This is in contrast to the bra...

A few centers have published promising early results for utilizing SBRT as a boost (UCSF, Georgetown, Flushing, Chi Mei Medical Center, Inha University Hospital), with perhaps a total of <300 patients reported on total. Efficacy and toxicity results appear to compare favorably with series of do...